Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs

Thorax

Volumn 55, Issue 5, 2000, Pages 355-358

  Elborn, J S ^a   Prescott, R J ^a   Stack, B H R ^a   Goodchild, M C ^a   Bates, J ^a   Pantin, C ^a   Ali, N ^a   Shale, D J ^a   Crane, M ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

Antibiotics; Cystic fibrosis; Maintenance treatment; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CYSTIC FIBROSIS; FORCED EXPIRATORY VOLUME; GRAM NEGATIVE INFECTION; HUMAN; LUNG FUNCTION; LUNG INFECTION; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHRONIC DISEASE; CYSTIC FIBROSIS; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; OPPORTUNISTIC INFECTIONS; PROSPECTIVE STUDIES; PSEUDOMONAS INFECTIONS; SPUTUM; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0034107646     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.55.5.355     Document Type: Article

References (19)

1. 1 Fitzsimmons S. The changing epidemiology of cystic fibrosis. J Paediatr 1993;122:1-9.
2. 2 Elborn JS, Shale DJ, Britton JR. Cystic fibrosis: current survival and population estimates to the year 2000. Thorax 1991;46:881-5.
3. 3 Dodge JS, Goodall J, Geddes D, et al. Cystic fibrosis in the United Kingdom 1977-85: an improving picture. BMJ 1988;297:1599-602.
4. 4 Elborn JS, Bell SC. Nutrition and Survival in cystic fibrosis. Thorax 1996;51:971-2.
5. 5 Govan JRW, Glass S. The microbiology and therapy of cystic fibrosis lung infections. Rev Med Microbiol 1990;1: 19-28.
6. 6 Hoiby N, Koch C. Pseudomonas aeruginosa infection in cystic fibrosis and its management. Thorax 1990;45:881-4.
7. 7 Pedersen SS, Koch C, Hoiby N, et al. An epidemic spread of multi-resistant Pseudomonas aeruginosa in a cystic fibrosis centre. J Antimicrob Chemother 1986;17:505-16.
8. 8 Valerius NH, Koch C, Hoiby N. Prevention of chronic P aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991;338:725-6.
9. 9 Frederiksen B, Koch C, Hoiby N. Antibiotic treatment of initial colonisation with P aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 1997;23:330-5.
10. 10 Denton M, Wilcox MH. Antimicrobial treatment of pulmonary colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. J Antimicrob Chemother 1997;40: 468-74.
11. 11 Ramsey BW. Management of pulmonary disease in patients with cystic fibrosis. Drug Therapy 1996;335:179-88.
12. 12 Norman D, Elborn JS, Cordon SM, et al. Plasma tumour necrosis factor alpha in cystic fibrosis. Thorax 1991;46:91-5.
13. 13 Szaff M, Hoiby N, Flensborg EW. Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta Paediatr Scand 1983;72:651-7.
14. 14 Nir M, Lanng S, Johansen K, et al. Long term survival and nutritional data in patients with cystic fibrosis treated in a Danish Centre. Thorax 1996;51:1023-7.
15. 15 David TJ. Cystic fibrosis. Arch Dis Child 1990;65:152-7.
16. 16 Chrispin AR, Norman AD. The systematic evaluation of the chest radiograph in cystic fibrosis. Pediatr Radiol 1974;2: 101-6.
17. 17 Webb AK, Govan JR. Burkholderia cepacia: another twist and a further threat. Thorax 1998,53:333-4.
18. 18 Cheng K, Smyth RL, Govan JRW, et al. Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 1996;348:639-42.
19. 19 Robson M, Abbott J, Webb AK, et al. A cost description of an adult cystic fibrosis unit and cost analysis of different categories of patients. Thorax 1992;47:484-9.